Vanderbilt investigators have developed a new analytical tool to identify, quantify and analyze small RNAs.

New findings demonstrate a previously unappreciated role of Shh signaling activity in the proliferation of CGNPs — the presumed cell-of-origin for a subset of the malignant pediatric brain tumor medulloblastoma.

New findings link flux through glycolysis, which produces cellular energy, with transcription and gene expression via histone modification.

Extracorporeal photopheresis treatment for stem cell transplant-related complications produces a response in up to 60 percent of patients.

Risk factors for arrhythmias after heart surgery in infants include medications, infant age and higher surgical complexity, but not two genetic variants examined by Vanderbilt researchers.

Vanderbilt researchers have identified a new vulnerability in lung cancer — the transporter protein xCT — that may a therapeutic target for the disease.

Activation of the signaling protein YAP may be a target for treating acute kidney injury, which affects up to 20 percent of hospitalized patients.